Abstract:BACKGROUND Various animal models have been used to explore the pathogenesis of choledochal cysts (CCs), but with little convincing results. Current surgical techniques can achieve satisfactory outcomes for treatment of CCs. Consequently, recent studies have focused more on clinical issues rather than basic research. Therefore, we need appropriate animal models to further basic research. AIM To establish an appropriate animal model that may contribute to the investigation of the pathogenesis of CCs. METHODS Eighty-four specific pathogen-free female Sprague-Dawley rats were randomly allocated to a surgical group, sham surgical group, or control group. A rat model of CC was established by partial ligation of the bile duct. The reliability of the model was confirmed by measurements of serum biochemical indices, morphology of common bile ducts of the rats as well as molecular biology experiments in rat and human tissues. RESULTS Dilation classified as mild (diameter, ≥ 1 mm to < 3 mm), moderate (≥ 3 mm to < 10 mm), and severe (≥ 10 mm) was observed in 17, 17, and 2 rats in the surgical group, respectively, while no dilation was observed in the control and sham surgical groups. Serum levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin, and total bile acids were significantly elevated in the surgical group as compared to the control group 7 d after surgery, while direct bilirubin, total bilirubin, and gamma-glutamyltransferase were further increased 14 d after surgery. Most of the biochemical indices gradually decreased to normal ranges 28 d after surgery. The protein expression trend of signal transducer and activator of transcription 3 in rat model was consistent with the human CC tissues. CONCLUSION The model of partial ligation of the bile duct of juvenile rats could morphologically simulate the cystic or fusiform CC, which may contribute to investigating the pathogenesis of CC.

Progresses in Animal Models and Drug Targets of Cholelithiasis

Research Process of Animal Model of Gouty Arthritis

Expression and Its Significance of Caveolin–1 in Liver and Gallbladder of Gallstone Mice Model

Experimental study on Shu Dan Tong granules in prevention and frecatment effects of cholelithiasis

Composition of bile and related changes in the mechanism of gallstone formation in Progress

Patient-derived Xenograft Models in Hepatopancreatobiliary Cancer

[Pathogenesis and animal model of gallstone disease]

Gastrointestinal microbiome and cholelithiasis: Current status and perspectives

Recent advances, novel targets and treatments for cholelithiasis; a narrative review

Research Advances in Animal Models of Primary Biliary Cholangitis

Research on Biliary Diseases: Progresses and Challenges

Animal models of calcium cholelithiasis

Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Preliminary exploration of animal models of congenital choledochal cysts

Establishment and evaluation of cholestatic mice model

Primary biliary cholangitis: molecular pathogenesis perspectives and therapeutic potential of natural products

The Pathogenesis, Models and Therapeutic Advances of Primary Biliary Cholangitis

Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma

Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention

The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models